Am J Transplant, Volume 21, Suppl 3 Archives - Page 113 of 139 - ATC Abstracts

2021 American Transplant Congress
Awareness of Teratogenic Potential of Mycophenolic Acid Products and Pregnancy Outcomes in Kidney Transplant Recipients
S. Rao¹, L. Coscia², A. Yusuf², S. Constantinescu³, M. J. Moritz⁴
¹Nephrology, University of Virginia Heath System, Charlottesville, VA, ²Transplant Pregnancy Registry International, Philadelphia, PA, ³Medicine, Lewis Katz School of Medicine at Temple University, Philadelphia, PA, ⁴Surgery, Lehigh Valley Health Network, Allentown, PA
*Purpose: In 2006, Transplant Pregnancy Registry International (TPRI) reported teratogenic effects of mycophenolic acid products (MPA) in pregnancies in transplant recipients. This resulted in black…
2021 American Transplant Congress
Which Living Kidney Donors Arrive to the Donation Process Informed About Surgery?
L. Malinzak, A. Segal, R. Prashar, M. Jesse
Henry Ford Hospital, Detroit, MI
*Purpose: To evaluate perceived knowledge about surgery in potential living kidney donors embarking on the donation process.*Methods: Potential living kidney donors were surveyed about their…
2021 American Transplant Congress
Robotic versus Open Mini-incision Living Donor Nephrectomy: Single Center Experience
S. Lee¹, S. Z. Wang², A. Khan¹, A. Sharma¹, D. Kumar³, L. Kamal³, A. Cotterell¹, V. Kumaran¹, D. Bruno¹, M. Levy¹, C. Bhati¹
¹Transplant Surgery, Virginia Commonwealth University hospital, Richmond, VA, ²Medical School, Virginia Commonwealth University, Richmond, VA, ³Transplant Nephrology, Virginia Commonwealth University hospital, Richmond, VA
*Purpose: A minimally invasive approach is the gold standard for living donor nephrectomy (LDN). While robotic surgery is commonly used for native nephrectomies and urological…
2021 American Transplant Congress
The Use of Donor Derived Cell Free DNA in Children to Monitor Therapy of Kidney Rejection
A. Al-Uzri, M. Wright, K. Clark, R. Jenkins
Oregon Health & Science Univ, Portland, OR
*Purpose: Elevated donor-derived cell-free DNA (dd-cfDNA) in the presence of HLA donor-specific antibodies (DSA) are shown to correlate with acute antibody-mediated rejection (AMR) in adult…
2021 American Transplant Congress
To Whom do Pediatric Donor Organs Go?
J. Smith¹, M. Skeans², R. Engen³, S. Bartosh⁴
¹Seattle Children's Hospital, Seattle, WA, ²SRTR, Minneapolis, MN, ³Lurie Children's Hospital, Chicago, IL, ⁴Univ of Wisconsin, Madison, WI
*Purpose: Pediatric priority in organ allocation is mandated by the Final Rule, but prioritization varies by organ, sometimes informed by size-matching needs. Heart (Policy 6.6.E)…
2021 American Transplant Congress
Combined Impact of Pre-sensitization and Delayed Graft Function on Allograft Rejection in Deceased Donor Kidney Transplantation: A Nationwide Cohort Study
H. Lee¹, Y. Park¹, T. Ban², S. Song³, S. Song⁴, J. Yang⁵, C. Ahn⁵, C. Yang¹, B. Chung¹
¹Division of Nephrology, Department of Internal Medicine, Seoul St. Mary’s hospital, Seoul, Korea, Republic of, ²Division of Nephrology, Department of Internal Medicine, Eunpyeong St. Mary’s hospital, Seoul, Korea, Republic of, ³Organ Transplantation Center and Department of Internal Medicine, Pusan National University Hospital, Pusan, Korea, Republic of, ⁴Department of Surgery, Ewha Womans University Medical Center, Seoul, Korea, Republic of, ⁵Department of Nephrology, Seoul National University Hospital, Seoul, Korea, Republic of
*Purpose: The aim of this study is to investigate whether or not delayed graft function (DGF) and pre-transplant sensitization has a synergistic adverse effect on…
2021 American Transplant Congress
Clazakizumab (clz, Anti-il-6 Antibody) Treatment Affects Il-6/il-6r Signaling by Increasing Soluble Gp130 (sgp130) in Hla-sensitized Kidney Transplant Patients (hs Ktx Pts) Treated for Chronic Antibody-mediated Rejection (cabmr)
B. Shin, S. Ge, A. Jimenez, N. Ammerman, A. Vo, R. Zhang, S. C. Jordan, M. Toyoda
Cedars-Sinai Medical Center, Cerritos, CA
*Purpose: IL-6 is a pro-inflammatory cytokine responsible for chronic vascular inflammation and a promising target for cABMR modulation. IL-6/sIL-6R complex initiates more pathogenic trans-signaling pathways…
2021 American Transplant Congress
PLA2R Status and Antibody Mediated Rejection in Kidney Transplant with Membranous Nephropathy
H. S. Han¹, A. Urisman², J. Shoji¹
¹Kidney Transplant Service, University of California, San Francisco, San Francisco, CA, ²Pathology, University of California, San Francisco, San Francisco, CA
*Purpose: Membranous nephropathy (MN) in transplanted kidney is categorized as de novo or recurrent disease. This immune complex glomerulopathy presents with varying levels of proteinuria,…
2021 American Transplant Congress
Biliary Complications Following Adult Deceased Donor Liver Transplantation: Risk Factors and Implications at a High-Volume US Center
A. Matar, K. Ross-Driscoll, L. Kenney, H. Wichmann, J. F. Magliocca, W. H. Kitchens
Emory Transplant Center, Atlanta, GA
*Purpose: Biliary leaks and anastomotic strictures comprise the majority of biliary complications (BCs) following liver transplantation. Most case series of BCs in adult deceased donor…
2021 American Transplant Congress
Blood Pressure Variability Immediately After Liver Transplant Predicts the Likelihood of Long-Term Cardiovascular Events
K. N. Truitt¹, K. Chen², Y. Yano³, D. Gregory⁴, L. B. VanWagner⁵
¹Northwestern Memorial Hospital, Chicago, IL, ²Harvard University, Cambridge, MA, ³Duke University School of Medicine, Durham, NC, ⁴Northwestern University Feinberg School of Medicine, Chicago, IL, ⁵Northwestern University Feinberg School of Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL
*Purpose: Cardiovascular disease is a leading cause of mortality in liver transplant recipients (LTRs). Adequate blood pressure (BP) control within one year after liver transplant…